Bicocca Open Archive

Logo unimib boa
BANDERA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.635
EU - Europa 1.184
AS - Asia 386
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
OC - Oceania 5
AF - Africa 4
Totale 4.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.555
IE - Irlanda 258
SE - Svezia 230
CN - Cina 223
DE - Germania 204
IT - Italia 166
UA - Ucraina 96
HK - Hong Kong 77
CA - Canada 70
GB - Regno Unito 67
DK - Danimarca 54
FI - Finlandia 37
VN - Vietnam 24
TR - Turchia 17
IN - India 15
BE - Belgio 12
RU - Federazione Russa 11
FR - Francia 10
AT - Austria 9
PL - Polonia 9
IR - Iran 7
SG - Singapore 7
EU - Europa 5
HN - Honduras 5
NL - Olanda 5
AU - Australia 4
BZ - Belize 4
BR - Brasile 3
ID - Indonesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
JP - Giappone 2
KR - Corea 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 4.227
Salva come PNG Salva come JPEG
Città #
Ann Arbor 375
Fairfield 276
Chandler 271
Dublin 253
Woodbridge 186
Houston 185
Wilmington 169
Frankfurt am Main 156
Ashburn 120
New York 112
Jacksonville 100
Seattle 98
Dearborn 96
Cambridge 94
Hong Kong 75
Princeton 71
Milan 56
Nanjing 41
Shanghai 37
Lawrence 32
Altamura 31
Ottawa 26
Fremont 21
Lachine 19
Nanchang 19
San Diego 19
Beijing 18
Dong Ket 18
Helsinki 16
Los Angeles 15
Buffalo 13
Andover 12
Brussels 12
Edmonton 12
Shenyang 12
London 11
Hebei 10
Kunming 9
Hangzhou 8
Kiev 8
Toronto 8
Falls Church 7
Guangzhou 7
Jinan 7
Norwalk 7
Tianjin 7
Vienna 7
Zhengzhou 7
Boardman 6
Changsha 6
Pune 6
Hanoi 5
Tegucigalpa 5
Belize City 4
Enterprise 4
Piacenza 4
Polska 4
San Francisco 4
Taizhou 4
Casper 3
Clearwater 3
Columbus 3
Darlington 3
Detroit 3
Edinburgh 3
Kilburn 3
Ningbo 3
Semarang 3
São Paulo 3
Acton 2
Aversa 2
Berlin 2
Buenos Aires 2
Carate Brianza 2
Dallas 2
Delhi 2
Foshan 2
Grassobbio 2
Groningen 2
Jiaxing 2
Lanzhou 2
Lisbon 2
Loreto 2
Miami 2
Montecchio Maggiore 2
Redmond 2
Rome 2
Saint Louis 2
San Mateo 2
Saronno 2
Seocho 2
Slough 2
Stockholm 2
Sulmona 2
Teramo 2
Tokyo 2
Washington 2
Willowdale 2
Airuno 1
Amsterdam 1
Totale 3.311
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 224
Effects of autologous stem cell transplantation in HIV: searching for the origins of viral replication in settings of profound CD4(+) T cell depletion 211
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 210
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 202
Microbiota in ICU, not only a gut problem 197
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 173
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 168
Brachial and central blood pressure in HIV-infected subjects 167
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 166
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial 164
ECMO: An alternative support for acute respiratory failure caused by tuberculosis? 161
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 155
Unmasking tuberculosis in the era of antiretroviral treatment 152
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 152
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 151
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 151
Impact of orotracheal intubation and mechanical ventilation on the microbiota of the lung in the development of Ventilator- Associated Pneumonia 149
Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies 148
Characterization of immune failure by monocyte activation phenotypes in HIV-infected patients receiving antiretroviral therapy 135
Strategies to limit immune-activation in HIV patients 134
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals 133
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 123
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 117
Exogenous reinfection of tuberculosis in a low-burden area 99
Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study 59
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 58
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 57
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 55
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 55
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 54
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 52
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 51
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 48
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 41
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 32
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 31
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 31
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 28
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 28
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 25
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 25
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 23
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 16
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 14
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 4.628
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019209 0 0 0 0 0 0 0 0 0 0 86 123
2019/2020992 101 67 74 69 83 116 108 75 108 88 81 22
2020/2021510 35 48 60 48 31 49 40 55 47 37 21 39
2021/2022474 15 21 46 60 20 48 21 36 23 55 29 100
2022/2023959 102 316 74 113 40 129 10 68 65 8 23 11
2023/2024676 19 14 46 32 92 217 144 37 52 23 0 0
Totale 4.628